Literature DB >> 18428141

High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.

Su Cheol Park1, Sook-Hyang Jeong, Jin Kim, Chul Ju Han, You Cheoul Kim, Kui Sung Choi, Jang Hyun Cho, Myoungjin Lee, Ha Hyun Jung, Seung Seog Ki, Yoon Hwan Chang, Seung Sook Lee, Yeon Hee Park, Kee Ho Lee.   

Abstract

This study assessed the association of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection with non-Hodgkin's lymphoma in a highly HBV-endemic area. The prevalence of either HBV or HCV infection in 235 patients with non-Hodgkin's lymphoma was compared with that of an age- and sex-matched hospital control group of 235 patients. The prevalence of HBV infection was higher in B-cell non-Hodgkin's lymphoma (15.5%) than control (8.1%), but the prevalence of HCV infection in the non-Hodgkin's lymphoma patients (2.1%) and control group (3%) was similar. HBV prevalence increased significantly with age in the B-cell non-Hodgkin's lymphoma patients. The presence of HBV proteins and DNA in lymphoma tissues and peripheral blood mononuclear cells (PBMCs) from HBV-infected non-Hodgkin's lymphoma patients was also investigated using immunohistochemistry and PCR. HBV DNA was frequently detected in PBMCs from HBV-infected non-Hodgkin's lymphoma patients, but HBV antigens were not. Therefore, HBV infection, but not HCV infection, was associated with B-cell non-Hodgkin's lymphoma in Korea, suggesting a possible role for HBV in the development of non-Hodgkin's lymphoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18428141     DOI: 10.1002/jmv.21168

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  24 in total

Review 1.  Hepatitis viruses and non-Hodgkin's lymphoma: A review.

Authors:  Sibnarayan Datta; Soumya Chatterjee; Rudragoud S Policegoudra; Hemant K Gogoi; Lokendra Singh
Journal:  World J Virol       Date:  2012-12-12

Review 2.  Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer.

Authors:  Clodoveo Ferri; Marco Sebastiani; Dilia Giuggioli; Michele Colaci; Poupak Fallahi; Alessia Piluso; Alessandro Antonelli; Anna Linda Zignego
Journal:  World J Hepatol       Date:  2015-03-27

3.  Hepatitis C virus infection among patients with non-Hodgkin's lymphoma in northern India.

Authors:  Subhash Varma; Madhav C Menon; Ashish Garg; Pankaj Malhotra; Arpita Sharma; Yogesh K Chawla; Radha K Dhiman
Journal:  Hepatol Int       Date:  2011-01-30       Impact factor: 6.047

4.  Associations between B-cell non-Hodgkin lymphoma and exposure, persistence and immune response to hepatitis B.

Authors:  Geffen Kleinstern; Rania Abu Seir; Riki Perlman; Ziad Abdeen; Areej Khatib; Husein Elyan; Eldad J Dann; Meirav Kedmi; Martin Ellis; Arnon Nagler; Gail Amir; Dina Ben Yehuda; Rifaat Safadi; Ora Paltiel
Journal:  Haematologica       Date:  2016-04-21       Impact factor: 9.941

5.  The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review.

Authors:  Fabrizio Marcucci; Enea Spada; Alfonso Mele; Carmelo Antonio Caserta; Alessandro Pulsoni
Journal:  Am J Blood Res       Date:  2012-01-01

6.  Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.

Authors:  Eric A Engels; Eo Rin Cho; Sun Ha Jee
Journal:  Lancet Oncol       Date:  2010-08-03       Impact factor: 41.316

7.  HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China.

Authors:  Zheng Wei; Shanhua Zou; Feng Li; Zhixiang Cheng; Junmin Li; Jianmin Wang; Chun Wang; Fangyuan Chen; Junning Cao; Yunfeng Cheng
Journal:  Med Oncol       Date:  2014-01-28       Impact factor: 3.064

Review 8.  Comparison of entecavir and lamivudine in preventing HBV reactivation in lymphoma patients undergoing chemotherapy: a meta-analysis.

Authors:  Sisi Yu; Huaichao Luo; Meiling Pan; Angel Palomino Luis; Zhujuan Xiong; Pin Shuai; Zhihui Zhang
Journal:  Int J Clin Pharm       Date:  2016-07-23

Review 9.  Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.

Authors:  Man Fai Law; Rita Ho; Carmen K M Cheung; Lydia H P Tam; Karen Ma; Kent C Y So; Bonaventure Ip; Jacqueline So; Jennifer Lai; Joyce Ng; Tommy H C Tam
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

10.  Genetic characterization of hepatitis B virus in peripheral blood leukocytes: evidence for selection and compartmentalization of viral variants with the immune escape G145R mutation.

Authors:  Sibnarayan Datta; Rajesh Panigrahi; Avik Biswas; Partha K Chandra; Arup Banerjee; Pradip K Mahapatra; Chinmoy K Panda; Shekhar Chakrabarti; Sujit K Bhattacharya; Kuntal Biswas; Runu Chakravarty
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.